Risk-Benefit Assessment of Amiodarone in the Treatment of Cardiac Arrhythmias
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 5 (4), 286-304
- https://doi.org/10.2165/00002018-199005040-00005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison between the efficacy of amiodarone and quinidine in the treatment of atrial cardiac arrhythmias.1986
- Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapyAmerican Heart Journal, 1983
- Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardiaAmerican Heart Journal, 1983
- Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndromeAmerican Heart Journal, 1983
- Amiodarone-induced polymorphous ventricular tachycardiaAmerican Heart Journal, 1983
- Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.Circulation, 1979
- [Hemodynamic effects of intravenous amiodarone in humans].1977
- Effect of amiodarone in the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1976
- Maintenance of sinus rhythm after atrial defibrillation.Heart, 1970
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970